Now I have enough calibration data to finalize my assessment. Let me write the final review.

## Summary
ProteinVista introduces a compute-efficient 3D CNN that voxelizes full-atom protein structures at 1.0Å resolution and pre-trains on ~500K AlphaFold-2 structures via contrastive alignment to ESM-2 embeddings. Under controlled comparisons with identical downstream pipelines, it outperforms ESM-2 on structure-dependent tasks (transporter-substrate classification, enzyme-substrate classification, and IC50 drug-target regression) while using ~5× fewer parameters and ~1% of pre-training GPU-hours.

## Strengths
- **Fair, controlled comparison methodology isolating the protein encoder**: All models (ProteinVista, ESM-2_150M, ESM-2_650M) are fine-tuned with identical prediction heads, identical MolFormer small-molecule embeddings, identical hyperparameter search, and an intentionally simple pipeline (Section 3.1, lines 87–95). This eliminates confounds from downstream architecture differences and makes the performance comparisons credible.
- **Large compute-efficiency gap with concrete numbers**: ProteinVista pre-trains in 48 hours on 4 A100 GPUs using ~0.5M structures, versus ESM-2's ~7 days on 128 H100 GPUs using ~250M sequences—roughly 1% of GPU-hours (Section 4.3, line 194). At inference, ProteinVista processes 1,000 proteins in 20 seconds on one A100 versus 426 seconds for ESM-2_650M (Section 4.3). These are specific, quantified efficiency gains.
- **Thorough ablation study quantifying each design choice**: Section 4.2 systematically varies components against the R²=0.69 IC50 baseline: reducing inference views from 5→1 drops R² by 6.4%; changing pre-training from contrastive to Rosetta regression drops by 1.0%; coarsening voxel resolution from 1.0Å to 1.5Å drops by 1.1%. This provides concrete evidence for each design decision.
- **Nuanced stratification revealing when structure vs. sequence models excel**: Section 4.1 partitions the transporter-substrate test set by sequence identity, TM-score structural similarity, and AlphaFold pLDDT confidence, showing ProteinVista outperforms ESM-2 at high identity/similarity, ESM-2 is better at low structural similarity, and the ensemble consistently helps. This is directly useful for practitioners deciding which encoder to use.
- **Honest reporting of failure modes**: Section 3.4 reports ProteinVista underperforms ESM-2 on GO annotation (F_max 0.57 vs. 0.62), and Table 2 shows the ensemble performs worse than ProteinVista alone on IC50. This strengthens credibility and supports the nuanced conclusion about complementarity.
- **Statistical significance testing**: McNemar's test confirms ensemble significantly outperforms ESM-2_650M on TSP (p < 10⁻¹³) and ESP (p < 10⁻¹⁷); Wilcoxon signed-rank test confirms ProteinVista significantly outperforms ESM-2_650M on IC50 (p < 10⁻³⁰⁴) (Section 3.2, lines 117–119).

## Weaknesses

### Fatal
None

### Major
- **Rotation invariance asserted but not demonstrated for continuous rotations**: The paper's central premise is applying a 3D CNN to proteins that lack canonical orientation. The solution relies on discrete 90° rotations and axis-mirror reflections (Section 2.4, line 79), which is a coarse subset of SO(3). The paper does not verify that the learned embeddings are quasi-invariant to arbitrary continuous rotations (e.g., by measuring embedding similarity under random rotations of the same protein). While multi-view inference (averaging 5 random augmented views) mitigates orientation sensitivity at test time—reducing this from 5 to 1 view drops R² by 6.4% (line 168)—this is a practical workaround, not a demonstration of learned invariance. A protein rotated by 30° would receive a completely different voxel assignment, and nothing in the paper verifies the model handles this gracefully. For a method intended for deployment on structures of arbitrary orientation, this validation gap is significant.
- **Title and abstract overclaim relative to experimental evidence**: The title ("outperforms sequence transformers") and abstract ("outperforms sequence transformers on three benchmarks") claim superiority over a class of models, but controlled comparisons (Section 3.2) only include ESM-2. No other sequence transformer (ProtT5, ProGen, etc.) is compared. Additionally, ProteinVista alone does not beat existing SOTA on TSP and ESP (Table 1: SPOT achieves 92.4% vs. ProteinVista's 90.8%; ProSmith-ESP achieves 94.2% vs. ProteinVista's 91.8%). Only the optimized-pipeline ensemble ESM-ProteinVista_OP achieves SOTA, which requires additional contrastive networks, fine-tuned MolFormer embeddings, and ensemble averaging—a substantially more complex pipeline than the "identical, simple pipeline" used for the primary comparisons (Section 3.3). The claims should be narrowed to match the evidence.

### Minor
- **No variance reporting across seeds or folds**: All results (Tables 1, 2) appear from single train/val/test splits with no standard deviations or confidence intervals. While statistical significance tests are provided (McNemar's, Wilcoxon), these test for differences on a single split rather than robustness across runs. For the IC50 task where the improvement margin is substantial (R² 0.69 vs. 0.61), variance estimates would strengthen confidence. (Note: this is common practice in the field and does not invalidate the results.)
- **Text-figure discrepancy in ablation values**: The text states "disabling rotational and mirror augmentations during fine-tuning had virtually no impact (-0.1%)" (line 168), while Figure 2e's table shows ~0.4% for "no training augmentation" (line 186). Similarly, the text says contrastive vs. Rosetta pre-training shows "+1.0%" (line 170) while the figure shows "~1.2%" (line 184). These should be reconciled.
- **Impact of cropping on large proteins not quantified**: Structures exceeding 160³ voxels are cropped at the bounding box (line 59). The paper does not quantify what fraction of pre-training or test data is affected, or how cropping affects performance. This is relevant for understanding the method's coverage, especially for large protein complexes.

### Trivial
- The storage requirement (75 GB for 5,800 transporter proteins as float32 coordinates vs. 3 MB for sequences, line 194) is acknowledged but no mitigation is discussed (e.g., sparse representations, compression). This limits practical scalability but the paper is transparent about the tradeoff.

## Nice-to-Haves
- Compare against at least one other sequence transformer (ProtT5) or structure-aware method (GearNet, ESM-GearNet) to substantiate the broader claim
- Test embedding invariance to continuous random rotations to validate the rotation robustness claim
- Report results across 3–5 random seeds for at least the IC50 and one classification task
- Discuss the teacher-student relationship: ProteinVista is pre-trained with ESM-2 alignment, so claiming to outperform ESM-2 creates a dependency that should be acknowledged
- Error analysis or case studies showing specific examples where ProteinVista correctly predicts binding that ESM-2 misses

## Removed Points
These points are flagged to be removed, treat them with caution:
- **Teacher-student circularity**: While ProteinVista is pre-trained with ESM-2 alignment, the contrastive objective encourages complementary structure information. Outperforming the teacher on structure-dependent tasks is a standard knowledge-distillation-then-surpass pattern, not genuine circularity. The paper could discuss this relationship, but it's not a flaw.
- **Storage concern as a weakness**: The paper explicitly acknowledges the storage tradeoff (line 194). This is transparent reporting, not an oversight.
- **Missing evaluation on fold classification/contact prediction**: Scope creep. The paper evaluates on structure-dependent binding tasks, which is its stated focus.

## Novel Insights
The stratified analysis in Section 4.1 provides a genuinely useful finding for practitioners: ProteinVista outperforms ESM-2 most at high sequence identity (where few substitutions have large structural effects) and on high-confidence AlphaFold structures (pLDDT > 90), while ESM-2 is better at low structural similarity. This suggests a practical decision rule: use structure encoders when reliable predicted structures are available and the target is well-represented in training data; rely on sequence models for novel folds. The finding that the ensemble helps in all regimes except the most structure-demanding task (IC50) is also informative for model selection.

## Suggestions
- Narrow the title to "outperforms ESM-2" or include comparisons to at least one additional PLM to support the broader claim
- Add a brief experiment measuring embedding cosine similarity under random continuous rotations of a held-out protein to validate rotation invariance
- Add a table reporting mean ± std for IC50 and one classification task across 3–5 seeds
- Reconcile the text-figure discrepancy in Section 4.2 ablation values
- Add a sentence acknowledging the contrastive pre-training dependency on ESM-2 when claiming to outperform ESM-2

## Calibration Reporting

**Round 1 anchors retrieved:**

| Paper | Path | Avg Score | Round | Comparison |
|-------|------|-----------|-------|------------|
| IC-Light (u1cQYxRI1H) | /.../u1cQYxRI1H.md | 0.50 | 1 | Unrelated topic (image harmonization); score noise |
| Time-dependent Scientific Discourse (P49gSPmrvN) | /.../P49gSPmrvN.md | 1.00 | 1 | Off-topic, trivial methodology — clearly below ProteinVista |
| Cross-Lingual Humanoid (gwZ90hFSL2) | /.../gwZ90hFSL2.md | 1.00 | 1 | Off-topic, no real contribution — clearly below |
| Financial Markets NN (nSDOkm0SKo) | /.../nSDOkm0SKo.md | 1.00 | 1 | Off-topic, speculative — clearly below |
| LEGO (rEQ8OiBxbZ) | /.../rEQ8OiBxbZ.md | 3.00 | 1 | 3D molecular pretraining; rejected for limited novelty and weak evaluation — ProteinVista is clearly stronger |
| ProteinAdapter (jqx5XI4Yr3) | /.../jqx5XI4Yr3.md | 3.40 | 1 | Fuses existing models (ESM-1b + structure), limited novelty, weak baselines — ProteinVista is stronger |
| GNNAS-Dock (An87ZnPbkT) | /.../An87ZnPbkT.md | 3.00 | 1 | Algorithm selection for docking — different problem, weaker evaluation |
| Ligand Conformation (m9zWBn1Y2j) | /.../m9zWBn1Y2j.md | 3.00 | 1 | Diffusion for ligand conformations — different problem, rejected |
| RapidDock (0sU4myabw1) | /.../0sU4myabw1.md | 4.25 | 1 | Molecular docking, overclaimed scope, missing baselines — ProteinVista has better controlled experiments |
| PPB affinity (xNDydjYBmC) | /.../xNDydjYBmC.md | 4.60 | 1 | PPB affinity prediction, missing baselines, no SOTA comparison — ProteinVista has fairer comparisons |
| ProteiNexus (iBAWiEjogY) | /.../iBAWiEjogY.md | 3.67 | 1 | Protein structural pretraining — rejected, weaker evaluation |
| DiffMaSIF (S4zpk61r6G) | /.../S4zpk61r6G.md | 4.67 | 1 | Diffusion for protein surfaces — different approach, comparable quality |
| AtomSurf (ARQIJXFcTH) | /.../ARQIJXFcTH.md | 6.75 | 1 | Surface representation for proteins, fair benchmark, SOTA on Atom3D — most comparable anchor, ProteinVista is slightly weaker (doesn't beat SOTA alone, narrower baselines) |
| Protein-ligand binding (AXbN2qMNiW) | /.../AXbN2qMNiW.md | 5.67 | 1 | Self-supervised binding pretraining, weaker experimental design — ProteinVista is stronger |
| MAPE-PPI (itGkF993gz) | /.../itGkF993gz.md | 5.67 | 1 | PPI prediction — ProteinVista has better evaluation |
| GroupBind (zDC3iCBxJb) | /.../zDC3iCBxJb.md | 6.75 | 1 | Group docking framework, SOTA — comparable quality, ProteinVista is close |

**Round 2 anchors retrieved:**

| Paper | Path | Avg Score | Round | Comparison |
|-------|------|-----------|-------|------------|
| ProteinWorkshop (sTYuRVrdK3) | /.../sTYuRVrdK3.md | 6.25 | 2 | Benchmark paper for protein structures — ProteinVista has more concrete method contribution |
| ProteinINR (BEH4mGo7zP) | /.../BEH4mGo7zP.md | 5.75 | 2 | Surface+structure pretraining, marginal improvements over ESM-GearNet — ProteinVista is stronger |
| SaProt (6MRm3G4NiU) | /.../6MRm3G4NiU.md | 7.33 | 2 | Structure-aware vocabulary PLM, broad SOTA — stronger contribution than ProteinVista |
| Structure Language Models (OzUNDnpQyd) | /.../OzUNDnpQyd.md | 7.00 | 2 | Protein conformation generation — different problem, strong contribution |
| ΔΔG predictor (IxmWIkcKs5) | /.../IxmWIkcKs5.md | 6.75 | 2 | Mutation effect prediction — different task, comparable quality |

**Bracket reasoning:**
- Round 1 bracket: 5.5–7.0. ProteinVista is clearly above the rejected papers (3.0–4.6) due to its controlled comparison methodology, thorough analysis, and genuine efficiency contribution. It is comparable to the accepted papers at 5.67–5.75 but stronger (better controlled experiments, more thorough ablations, compute analysis, honest negative results). It is slightly below AtomSurf (6.75) because ProteinVista doesn't beat SOTA alone and has narrower baseline comparisons.
- Round 2 narrowing: 6.0–6.5. ProteinVista is above ProteinINR (5.75) and ProteinWorkshop (6.25 is a benchmark paper with less novelty), but below SaProt (7.33) which has broader impact and cleaner SOTA claims. The score of 6.5 reflects a solid contribution with genuine strengths that is somewhat held back by overclaiming in the title/abstract and the rotation invariance validation gap.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>